Last update Jan. 17, 2026
Limited compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Hexavalent Chromium( Cr 6, Cr VI) compounds is also known as
Hexavalent Chromium( Cr 6, Cr VI) compounds in other languages or writings:
Hexavalent Chromium( Cr 6, Cr VI) compounds belongs to this group or family:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by AELAMA of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Just as trivalent chromium compounds (3+, III) are non-toxic at appropriate doses and constitute an essential nutritional trace element, hexavalent chromium salts (6+, VI: see list of synonyms) have industrial uses (chrome plating, stainless steel), are oxidising, corrosive, irritating, and are classified as carcinogens 1A and mutagens 1B (Wise 2025, Jiang 2025, Guo 2013, Panreac 2011, WHO-OMS 2012, ATSDR 2012, INSHT 2012, 2010 & 2004, Patlolla 2009, IARC 1990), can cause contact dermatitis and severe chronic and acute toxicity (Hald 2009, Lin 2009, André 1998). Chromium 6+ is also found in tobacco smoke (ATSDR 2012), cosmetics (Hepp 2014) and some osteoarticular prostheses. (Oppermann 2015, Nelis 2013)
Due to their hazardous nature, hexavalent chromium compounds currently have no medical uses.
In terms of occupational risk for breastfeeding mothers (INSHT 2024, EC Regulation 2008), there are only two risk phrases (formerly R phrases, now H phrases for Hazard) or precautionary phrases (P phrases) in a product's safety data sheet that are relevant to breastfeeding:
Six other phrases that should be considered during breastfeeding are related to the carcinogenic, mutagenic or cumulative power of a product:
The Cr(VI) data sheet includes phrases H350 (R45) and H372 (R48) (INSHT 2012, 2010 & 2004, Panreac 2011), which, based on current European regulations (EC Regulation 2008), which states that when a product is carcinogenic and mutagenic, working breastfeeding mothers should not be exposed to mixtures, whether solid, liquid or gaseous, with concentration limits above 0.3%, we consider that breastfeeding mothers should not be exposed to hexavalent chromium compounds in the workplace.
There is no increase in chromium concentrations in milk or problems in infants breastfed by mothers with hip prostheses containing chromium in their composition. (Oppermann 2015, Nelis 2013)
See below the information of this related product: